Patients with relapsing B-cell dependent rheumatologic diseases experience joint pain and tissue damage because their B-cells become overactive and trigger multiple disease flare-ups. The category includes rheumatoid arthritis and lupus causing symptoms that improve and worsen unpredictably. The cycles of relapse disrupt mobility and energy levels, creating difficulties for patients who need to plan their daily activities.
The existing treatments focus on immune system suppression and flare-up reduction, yet doctors find it challenging to attain permanent remission for their patients. Through clinical trial participation, patients gain access to specific B-cell therapies which aim to improve relapse prevention and decrease disease progression while achieving better long-term management results.
Interested in learning more about participation in our clinical research studies? Determine your eligibility by responding to a brief set of inquiries. By completing the form below, you grant us permission to connect with you via phone, text, or email, offering further details through our research team.
If these health challenges disrupt your daily routine, you might be eligible for a clinical research opportunity. Feel free to reach out by filling out the form provided or giving us a call. Once you've submitted, one of our specialized team members at Biopharma will promptly get in touch with you.